Company: FVR
Filing Date: 2025-04-17
Form Type: DEF 14A
Source: 0000950170-25-055535
Chunk: 32

Company: FrontView REIT, Inc.
Filing Date: 2025-04-17
Form: DEF 14A
Chunk 32
---
 executive officer’s continued service with the Company through the applicable vesting date. The IPO Grants may also be subject to accelerated vesting in certain circumstances pursuant to the terms of the applicable named executive officer’s employment agreement. Additional detail regarding the accelerated vesting provisions found in each named executive officer’s employment agreement is set forth under the heading “—Additional Narrative Disclosure” below. (2) The value of the IPO Grants is shown assuming a market value of $18.13 per share, the closing market price of a share of our Common Stock on December 31, 2024. Additional Narrative Disclosure The employment agreements with Messrs. Preston, Starr, Dieffenbacher and Ireland provide for payments and benefits to the named executive officers in connection with certain terminations of employment. In the event of the named executive officer’s termination of employment by the Company without “cause,” by the named executive officer for “good reason” or due to the named executive officer’s death or “disability” (as such terms are defined in the employment agreement) outside of the period beginning three months prior to or and ending 24 months following a change in control of the Company (the “Change in Control Window”) under each named executive officer’s employment agreement, the named executive officer is entitled to receive: (i) accrued benefits, consisting of unpaid base salary and accrued but unused vacation or paid time off through the date of termination, reimbursement for all reasonable out-of-pocket business expenses incurred and paid by the named executive officer through date of termination, and vested benefits under Company benefit plans (collectively, the “Accrued Benefits”); (ii) a lump sum payment equal to (A) in the case of termination by the Company without “cause” or by the named executive officer for “good reason,” two times and (B) in the case of termination due to death or “disability,” one and one-half times the sum of the named executive officer’s base salary and two-year average annual bonus, in the case of Messrs. Preston and Starr, or one times the sum of the named executive officer’s base salary and two-year average annual bonus, in the case of Messrs. Dieffenbacher and Ireland; (iii) any earned but unpaid annual bonus for the prior calendar year; (iv) an amount equal to the named executive officer’s target bonus for the year of termination, prorated through the date of termination; (v) reimbursement for the named executive officer’s health insurance continuation coverage at the active-employee rate for